NATIONAL CENTER OF BIOPRODUCTS
Trials shown by sponsor
Public title | Date of Registration | State |
---|---|---|
Evidence of the clinical efficacy of VALERGEN-BT vaccine in asthmatics | 2010-12-09 | Registered |
Efficacy of VALERGEN-DP sublingual vaccine in asthmatic adults. | 2010-12-09 | Registered |
Evidence of the clinical efficacy of VALERGEN-DP vaccine in asthmatics | 2010-12-09 | Registered |
Sublingual immunotherapy with VALERGEN-Asthma-Children-Phase II | 2012-04-02 | Registered |
Combined Subcutaneous immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II | 2012-04-13 | Registered |
Subcutaneous immunotherapy with PROLINEM -Asthma- Adults-Fase I | 2013-01-04 | Registered |
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study | 21/12/2020 | Registered |
Pharmacovigilance-VALERGEN-Asthma | 27/01/2017 | Registered |
Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis | 28/05/2020 | Registered |
Biomodulina T - IM - covid-19 - older adult | 29/05/2020 | Registered |